Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas. Neblett MF 2nd, Stewart EA. Obstet Gynecol 2023;141:901-910.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Neblett MF 2nd, Stewart EA. Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas. Obstet Gynecol 2023;141:901-910.
PMID: 37103532